↓ Skip to main content

A phase I dose-escalation study of selumetinib in combination with docetaxel or dacarbazine in patients with advanced solid tumors

Overview of attention for article published in BMC Cancer, March 2017
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
44 Mendeley